# Ketones in Cardiovascular Health and Disease: An Updated Review

**Authors:** Sanjiv Shrestha, Isis Harrison, Aminat Dosunmu, Ping Song

PMC · DOI: 10.3390/cells15020150 · Cells · 2026-01-14

## TL;DR

This paper reviews how ketones affect cardiovascular health and disease, highlighting their role as energy sources and signaling molecules.

## Contribution

The paper updates the understanding of ketone metabolism and introduces β-hydroxybutyrylation as a key molecular mechanism in cardiovascular regulation.

## Key findings

- Ketones influence cardiovascular health through β-hydroxybutyrylation, a post-translational modification.
- Ketone interventions may offer therapeutic benefits for heart failure and vascular dysfunction.
- Ketone therapy effectiveness varies by gender and age, requiring personalized approaches.

## Abstract

What are the main findings?
Ketones function as alternative energy sources and signaling molecules that regulate cardiovascular health and diseases.The post-translational modification mediated by β-hydroxybutyrylation controls the fate and function of target proteins and their biological roles.

Ketones function as alternative energy sources and signaling molecules that regulate cardiovascular health and diseases.

The post-translational modification mediated by β-hydroxybutyrylation controls the fate and function of target proteins and their biological roles.

What are the implications of the main findings?
Ketone intervention may serve as a promising therapeutic approach for cardiovascular diseases, such as heart failure, acute cardiac injury, and vascular dysfunction.Future ketone therapies should take into account the side effects of the ketogenic diet, as well as gender- and age-specific variations in the effectiveness of ketone treatments.

Ketone intervention may serve as a promising therapeutic approach for cardiovascular diseases, such as heart failure, acute cardiac injury, and vascular dysfunction.

Future ketone therapies should take into account the side effects of the ketogenic diet, as well as gender- and age-specific variations in the effectiveness of ketone treatments.

Ketones are metabolites primarily produced by the liver and are utilized by various organs outside of the liver. Recent advances have demonstrated that ketones serve not only as alternative energy sources but also as signaling molecules. Research indicates that ketones can influence cancer development and metastasis, cardiac metabolic and structural remodeling, physical performance, vascular function, inflammation, and the aging process. Emerging evidence from preclinical and early-phase clinical studies suggests that strategies such as ketone salts, ketone esters, and the ketogenic diet may offer therapeutic benefits for conditions like heart failure, acute cardiac injury, diabetic cardiomyopathy, vascular complications, atherosclerosis, hypertension, and aortic aneurysm. This literature review updates the current understanding of ketone metabolism and its contributions to cardiovascular health and diseases. We highlight the underlying molecular mechanism with post-translational modification known as β-hydroxybutyrylation, which affects the fate and function of target proteins. Additionally, we discuss the therapeutic challenges associated with ketone therapy, the potential of using ketone levels as biomarkers for cardiovascular diseases, as well as gender- and age-specific differences in ketone treatment. Finally, we explore future research directions and what is needed to translate these new insights into cardiovascular medicine.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252), atherosclerosis (MONDO:0005311), aortic aneurysm (MONDO:0005160)

## Full-text entities

- **Diseases:** diabetic cardiomyopathy (MESH:D058065), cancer (MESH:D009369), aortic aneurysm (MESH:D001014), Health and Disease (OMIM:603663), hypertension (MESH:D006973), inflammation (MESH:D007249), cardiac injury (MESH:D006331), metastasis (MESH:D009362), vascular complications (MESH:D003925), atherosclerosis (MESH:D050197), cardiovascular diseases (MESH:D002318), heart failure (MESH:D006333)
- **Chemicals:** ketone esters (-), Ketones (MESH:D007659)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12838954/full.md

## References

134 references — full list in the complete paper: https://tomesphere.com/paper/PMC12838954/full.md

---
Source: https://tomesphere.com/paper/PMC12838954